Trastuzumab in Treating Older Women With Early-Stage Breast Cancer

Summary

RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. PURPOSE: This phase II trial is studying the side effects of trastuzumab and to see how well it works in treating older women with early-stage breast cancer.

Timeline

Start

2009-02-05

Primary completion

2016-01-06

Completion

2020-02-26

Drugs

Indications